JP2013528161A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013528161A5 JP2013528161A5 JP2013510284A JP2013510284A JP2013528161A5 JP 2013528161 A5 JP2013528161 A5 JP 2013528161A5 JP 2013510284 A JP2013510284 A JP 2013510284A JP 2013510284 A JP2013510284 A JP 2013510284A JP 2013528161 A5 JP2013528161 A5 JP 2013528161A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- subject
- hydrogen
- salt
- ion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 15
- 239000001257 hydrogen Substances 0.000 claims 15
- 150000003839 salts Chemical class 0.000 claims 14
- -1 ascorbate ion Chemical class 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 12
- 125000004404 heteroalkyl group Chemical group 0.000 claims 12
- 150000002431 hydrogen Chemical class 0.000 claims 11
- 238000000034 method Methods 0.000 claims 11
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 125000003118 aryl group Chemical group 0.000 claims 9
- 125000000753 cycloalkyl group Chemical group 0.000 claims 9
- 125000001188 haloalkyl group Chemical group 0.000 claims 9
- 125000001072 heteroaryl group Chemical group 0.000 claims 9
- 125000000623 heterocyclic group Chemical group 0.000 claims 9
- 239000012458 free base Substances 0.000 claims 7
- 102000008092 Norepinephrine Plasma Membrane Transport Proteins Human genes 0.000 claims 6
- 108010049586 Norepinephrine Plasma Membrane Transport Proteins Proteins 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000003282 alkyl amino group Chemical group 0.000 claims 3
- 150000001356 alkyl thiols Chemical class 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 230000017531 blood circulation Effects 0.000 claims 3
- 150000004820 halides Chemical class 0.000 claims 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 3
- 238000003384 imaging method Methods 0.000 claims 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical class [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims 2
- 229940072107 ascorbate Drugs 0.000 claims 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- 230000000747 cardiac effect Effects 0.000 claims 2
- 210000000748 cardiovascular system Anatomy 0.000 claims 2
- 230000030214 innervation Effects 0.000 claims 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- KRHYYFGTRYWZRS-BJUDXGSMSA-N ac1l2y5h Chemical compound [18FH] KRHYYFGTRYWZRS-BJUDXGSMSA-N 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- 239000002872 contrast media Substances 0.000 claims 1
- 230000004807 localization Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 229940085991 phosphate ion Drugs 0.000 claims 1
- VXBMBABPSKFIMW-UHFFFAOYSA-N CC(C)(C)OC(N(Cc(cc1)cc(Br)c1OCCCOS(c1ccc(C)cc1)=O)/C(/N)=N\C(OC(C)(C)C)=O)=O Chemical compound CC(C)(C)OC(N(Cc(cc1)cc(Br)c1OCCCOS(c1ccc(C)cc1)=O)/C(/N)=N\C(OC(C)(C)C)=O)=O VXBMBABPSKFIMW-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33361810P | 2010-05-11 | 2010-05-11 | |
| US61/333,618 | 2010-05-11 | ||
| US40552410P | 2010-10-21 | 2010-10-21 | |
| US40557110P | 2010-10-21 | 2010-10-21 | |
| US61/405,571 | 2010-10-21 | ||
| US61/405,524 | 2010-10-21 | ||
| PCT/US2011/036142 WO2011143360A2 (en) | 2010-05-11 | 2011-05-11 | Compositions, methods and systems for the synthesis and use of imaging agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016160146A Division JP6216421B2 (ja) | 2010-05-11 | 2016-08-17 | 造影剤の合成および使用のための組成物、方法およびシステム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013528161A JP2013528161A (ja) | 2013-07-08 |
| JP2013528161A5 true JP2013528161A5 (cg-RX-API-DMAC7.html) | 2014-06-26 |
| JP5992399B2 JP5992399B2 (ja) | 2016-09-14 |
Family
ID=44914968
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013510284A Active JP5992399B2 (ja) | 2010-05-11 | 2011-05-11 | 造影剤の合成および使用のための組成物、方法およびシステム |
| JP2016160146A Active JP6216421B2 (ja) | 2010-05-11 | 2016-08-17 | 造影剤の合成および使用のための組成物、方法およびシステム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016160146A Active JP6216421B2 (ja) | 2010-05-11 | 2016-08-17 | 造影剤の合成および使用のための組成物、方法およびシステム |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US9388125B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2569019B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5992399B2 (cg-RX-API-DMAC7.html) |
| KR (4) | KR102136503B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN106977429B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011253052B2 (cg-RX-API-DMAC7.html) |
| BR (4) | BR122020018186B1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2798488C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2569019T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2763815T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL222897A (cg-RX-API-DMAC7.html) |
| MX (3) | MX383896B (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ604233A (cg-RX-API-DMAC7.html) |
| RU (2) | RU2710736C2 (cg-RX-API-DMAC7.html) |
| SG (1) | SG185424A1 (cg-RX-API-DMAC7.html) |
| TW (2) | TWI606842B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011143360A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2474523B1 (en) | 2006-12-26 | 2020-04-08 | Lantheus Medical Imaging, Inc. | Ligands for imaging cardiac innervation |
| JP5662416B2 (ja) | 2009-04-15 | 2015-01-28 | ランセウス メディカル イメージング， インコーポレイテッド | アスコルビン酸による放射性医薬組成物の安定化 |
| BR112012019789A2 (pt) | 2010-02-08 | 2016-08-09 | Lantheus Medical Imaging Inc | métodos e aparelhos para sintetizar agentes de imagiologia, e seus intermediários |
| WO2011143360A2 (en) * | 2010-05-11 | 2011-11-17 | Lantheus Medical Imaging, Inc. | Compositions, methods and systems for the synthesis and use of imaging agents |
| BR122019017259B1 (pt) | 2011-09-09 | 2022-05-10 | Lantheus Medical Imaging, Inc | Compostos úteis como agentes de imageamento, composições que os compreende, métodos, e uso de agentes de imageamento |
| US20150023873A1 (en) | 2011-11-11 | 2015-01-22 | Lantheus Medical Imaging, Inc. | Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging |
| CN104244991A (zh) | 2012-04-10 | 2014-12-24 | 蓝瑟斯医学影像公司 | 放射性药物合成方法 |
| AU2013203000B9 (en) * | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
| WO2014052454A1 (en) | 2012-09-25 | 2014-04-03 | The Regents Of The University Of Michigan | Imaging agents |
| CN107106710A (zh) * | 2014-10-24 | 2017-08-29 | 分子制药洞察公司 | 间‑碘苄基胍及其前体的制剂 |
| WO2016138448A1 (en) * | 2015-02-27 | 2016-09-01 | Schmitthenner Hans F | Transmetalation methods for the synthesis of pet and spect imaging agents |
| US10368774B2 (en) | 2015-07-30 | 2019-08-06 | Medtronic, Inc. | Absolute intrathoracic impedance based scheme to stratify patients for risk of a heart failure event |
| US10874752B2 (en) | 2015-09-25 | 2020-12-29 | Board Of Regents Of The University Of Nebraska | MIBG analogs and uses thereof |
| US10918742B2 (en) | 2016-03-25 | 2021-02-16 | Nanoprobes, Inc. | Iodine-based particles |
| US10695450B2 (en) | 2016-07-26 | 2020-06-30 | Laboratoires Cyclopharma | Synthesis of a radioactive agent composition |
| FR3054445B1 (fr) * | 2016-07-26 | 2019-07-05 | Laboratoires Cyclopharma | Synthese d'une composition d'agent radioactif |
| US10924560B2 (en) * | 2018-07-30 | 2021-02-16 | Facebook, Inc. | Determining geographic locations of network devices |
| WO2020085238A1 (ja) * | 2018-10-24 | 2020-04-30 | 日本メジフィジックス株式会社 | 放射性フッ素標識前駆体化合物の塩 |
| CN111366643B (zh) * | 2018-12-25 | 2022-08-19 | 广东阿格蕾雅光电材料有限公司 | 一种oled材料中间体的检测方法 |
| RU196435U1 (ru) * | 2019-12-30 | 2020-02-28 | федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский ядерный университет "МИФИ" (НИЯУ МИФИ) | Устройство для позитронно-эмиссионной томографии |
| NL2031332B1 (en) * | 2022-03-18 | 2023-09-29 | Plethora Therapeutics B V | Transmucosal delivery of psychoactive compounds |
| CN116351339A (zh) * | 2022-06-07 | 2023-06-30 | 北京先通国际医药科技股份有限公司 | 一种液体组合物的生产设备及其制备方法和用途 |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1010218A (fr) * | 1949-02-10 | 1952-06-09 | American Cyanamid Co | Perfectionnements aux sels de guanidine |
| US3291829A (en) * | 1961-03-02 | 1966-12-13 | Ciba Geigy Corp | Alkyl guanidines |
| GB1215255A (en) * | 1968-03-13 | 1970-12-09 | Pfizer & Co C | Halophenylalkylguanidine compounds |
| US4094881A (en) | 1976-03-10 | 1978-06-13 | Smithkline Corporation | Process for preparing triazolethiols |
| US4275074A (en) * | 1979-03-09 | 1981-06-23 | Graham J. Dobbie | Catecholamine treatment of ocular hypertension |
| US4270537A (en) | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
| US4258188A (en) | 1980-02-04 | 1981-03-24 | American Home Products Corporation | 2-(1-Piperazinyl)-cycloheptimidazole derivatives |
| US4622217A (en) | 1984-04-27 | 1986-11-11 | The Regents Of The University Of Michigan | I-4-amino-3-iodobenzylguanidine as imaging and therapeutic agent |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4886499A (en) | 1986-12-18 | 1989-12-12 | Hoffmann-La Roche Inc. | Portable injection appliance |
| GB8704027D0 (en) | 1987-02-20 | 1987-03-25 | Owen Mumford Ltd | Syringe needle combination |
| EP0288284A3 (en) | 1987-04-24 | 1990-07-25 | King Faisal Specialist Hospital And Research Centre | Method of producing iodine 124 and meta-iodobenzylguanidine containing iodine 124 |
| US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US5339163A (en) | 1988-03-16 | 1994-08-16 | Canon Kabushiki Kaisha | Automatic exposure control device using plural image plane detection areas |
| FR2638359A1 (fr) | 1988-11-03 | 1990-05-04 | Tino Dalto | Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5190521A (en) | 1990-08-22 | 1993-03-02 | Tecnol Medical Products, Inc. | Apparatus and method for raising a skin wheal and anesthetizing skin |
| US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
| GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
| SE9102652D0 (sv) | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | Injection needle arrangement |
| US5328483A (en) | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
| US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
| WO1995024176A1 (en) | 1994-03-07 | 1995-09-14 | Bioject, Inc. | Ampule filling device |
| US5466220A (en) | 1994-03-08 | 1995-11-14 | Bioject, Inc. | Drug vial mixing and transfer device |
| US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
| US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
| JP3356289B2 (ja) | 1995-06-26 | 2002-12-16 | コンキャット リミティド | 第一遷移系列元素に対してキレート化親和性および選択性のある化合物とその医療および診断への使用 |
| US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
| GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
| TW499412B (en) | 1996-11-26 | 2002-08-21 | Dimensional Pharm Inc | Aminoguanidines and alkoxyguanidines as protease inhibitors |
| US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
| WO1999018053A1 (en) | 1997-10-02 | 1999-04-15 | The University Of Western Ontario | Preparation of radiolabelled haloaromatics via polymer-bound intermediates |
| IT1298087B1 (it) | 1998-01-08 | 1999-12-20 | Fiderm S R L | Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni |
| AU3406599A (en) | 1998-04-09 | 1999-11-01 | Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin | Novel benzyl guanidine derivatives for therapy and (in-vivo) and (in-vitro) diagnosis |
| WO2000009115A1 (en) * | 1998-08-14 | 2000-02-24 | Smithkline Beecham Corporation | Grp receptor ligands |
| BR9917079A (pt) | 1998-12-18 | 2001-10-30 | Du Pont Pharm Co | Compostos antagonistas de receptor devitronectina, kit, composição metalofarmacêuticade diagnóstico ou terapêutica, composição deagente de contraste para ultra-som, composiçãoradiofarmacêutica terapêutica, composiçãofarmacêutica de diagnóstico, método detratamento da artrite reumatóide, do cancêr e darestenose em um paciente, método de formação deimagem da angiogênese terapêutica, do câncer, denovos vasos sanguìneos, da arteriosclerose, darestenose, da isquemia e da lesão por reperfusãodo miocárdio em um paciente |
| US6656448B1 (en) | 2000-02-15 | 2003-12-02 | Bristol-Myers Squibb Pharma Company | Matrix metalloproteinase inhibitors |
| GB0019357D0 (en) | 2000-08-07 | 2000-09-27 | Melacure Therapeutics Ab | Novel phenyl guanidines |
| DE10114561A1 (de) * | 2001-03-24 | 2002-09-26 | Wella Ag | Verwendung von Mitteln enthaltend Kreatin, Kreatin und/oder deren Derivaten zur Verstärkung und Strukturverbesserung von keratinischen Fasern |
| US7344702B2 (en) | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
| US20060113968A1 (en) | 2002-08-17 | 2006-06-01 | Altana Pharma Ag | Novel benzonaphthyridines |
| AU2003298582A1 (en) * | 2002-09-17 | 2004-05-13 | Isis Pharmaceuticals, Inc. | Therapeutic guanidines |
| EP1641493A4 (en) | 2003-06-30 | 2007-10-31 | Merck & Co Inc | RADIOACTIVELY MARKED CANNABINOID-1 RECEPTOR MODULATORS |
| CA2549141C (en) | 2003-12-01 | 2012-10-23 | Medi-Physics, Inc. | Novel differential imaging method |
| US20060100225A1 (en) | 2004-03-23 | 2006-05-11 | Xi Chen | Heteroaryl guanidines; inhibitors of viral replication |
| EP1749815B1 (en) | 2004-05-28 | 2017-06-21 | Hamamatsu Photonics K.K. | Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor |
| ATE493152T1 (de) | 2004-09-23 | 2011-01-15 | Guerbet Sa | Liposomale kontrastmittel für die cest-bildgebung |
| US20060083681A1 (en) | 2004-10-18 | 2006-04-20 | Ajay Purohit | Compounds for myocardial perfusion imaging |
| US7534418B2 (en) * | 2004-12-10 | 2009-05-19 | The Regents Of The University Of Michigan | Imaging agents |
| GB0512770D0 (en) | 2005-06-23 | 2005-07-27 | Hammersmith Imanet Ltd | Imaging compounds |
| AU2007332641A1 (en) | 2006-12-13 | 2008-06-19 | F. Hoffmann-La Roche Ag | Novel 2 -imidazoles as ligands for trace amine associated receptors (TAAR) |
| GB0625523D0 (en) * | 2006-12-21 | 2007-01-31 | Ge Healthcare Ltd | In vivo imaging agents |
| EP2474523B1 (en) * | 2006-12-26 | 2020-04-08 | Lantheus Medical Imaging, Inc. | Ligands for imaging cardiac innervation |
| WO2008082305A1 (en) | 2006-12-28 | 2008-07-10 | Raufoss Technology As | Control arm |
| US8153100B2 (en) * | 2007-01-11 | 2012-04-10 | Immunomedics, Inc. | Methods and compositions for F-18 labeling of proteins, peptides and other molecules |
| US7887784B2 (en) * | 2007-03-21 | 2011-02-15 | University Of Montana | 1-[(2′-substituted)-piperazin-1′ -yl]-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents |
| US7807394B2 (en) | 2007-04-05 | 2010-10-05 | Siemens Medical Solutions Usa, Inc. | Nitro-imidazole hypoxia imaging agents |
| CN101585816B (zh) | 2008-05-20 | 2011-04-20 | 中国科学院上海应用物理研究所 | 一种苯磺酰胺类羟基衍生物及其中间体及制备方法和应用 |
| WO2010015340A1 (en) * | 2008-08-06 | 2010-02-11 | Bayer Schering Pharma Aktiengesellschaft | Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment |
| GB0906274D0 (en) | 2009-04-09 | 2009-05-20 | Ge Healthcare Ltd | Imaging the central nervous system |
| JP5662416B2 (ja) | 2009-04-15 | 2015-01-28 | ランセウス メディカル イメージング， インコーポレイテッド | アスコルビン酸による放射性医薬組成物の安定化 |
| CN101555232B (zh) | 2009-05-21 | 2011-01-05 | 北京师范大学 | 氟-18标记哒嗪酮类化合物及制备方法和应用 |
| EP2451776B1 (en) | 2009-07-08 | 2019-09-18 | Lantheus Medical Imaging, Inc. | N-alkoxyamide conjugates as imaging agents |
| BR112012019789A2 (pt) | 2010-02-08 | 2016-08-09 | Lantheus Medical Imaging Inc | métodos e aparelhos para sintetizar agentes de imagiologia, e seus intermediários |
| WO2011143360A2 (en) | 2010-05-11 | 2011-11-17 | Lantheus Medical Imaging, Inc. | Compositions, methods and systems for the synthesis and use of imaging agents |
| BR122019017259B1 (pt) | 2011-09-09 | 2022-05-10 | Lantheus Medical Imaging, Inc | Compostos úteis como agentes de imageamento, composições que os compreende, métodos, e uso de agentes de imageamento |
-
2011
- 2011-05-11 WO PCT/US2011/036142 patent/WO2011143360A2/en not_active Ceased
- 2011-05-11 BR BR122020018186-9A patent/BR122020018186B1/pt active IP Right Grant
- 2011-05-11 BR BR122020018191-5A patent/BR122020018191B1/pt active IP Right Grant
- 2011-05-11 MX MX2019009780A patent/MX383896B/es unknown
- 2011-05-11 TW TW100116554A patent/TWI606842B/zh not_active IP Right Cessation
- 2011-05-11 ES ES11781241T patent/ES2763815T3/es active Active
- 2011-05-11 TW TW105132631A patent/TWI592391B/zh not_active IP Right Cessation
- 2011-05-11 MX MX2016010906A patent/MX367382B/es unknown
- 2011-05-11 CA CA2798488A patent/CA2798488C/en active Active
- 2011-05-11 KR KR1020197022611A patent/KR102136503B1/ko not_active Expired - Fee Related
- 2011-05-11 AU AU2011253052A patent/AU2011253052B2/en active Active
- 2011-05-11 EP EP11781241.2A patent/EP2569019B1/en active Active
- 2011-05-11 NZ NZ604233A patent/NZ604233A/en not_active IP Right Cessation
- 2011-05-11 DK DK11781241.2T patent/DK2569019T3/da active
- 2011-05-11 EP EP19200889.4A patent/EP3653230B1/en active Active
- 2011-05-11 KR KR1020187015363A patent/KR102008635B1/ko not_active Expired - Fee Related
- 2011-05-11 CA CA3041113A patent/CA3041113C/en active Active
- 2011-05-11 KR KR1020127032221A patent/KR101726471B1/ko not_active Expired - Fee Related
- 2011-05-11 CN CN201611178266.0A patent/CN106977429B/zh not_active Expired - Fee Related
- 2011-05-11 US US13/697,287 patent/US9388125B2/en active Active
- 2011-05-11 BR BR112012028806-7A patent/BR112012028806B1/pt not_active IP Right Cessation
- 2011-05-11 KR KR1020177009313A patent/KR20170042373A/ko not_active Ceased
- 2011-05-11 RU RU2012153210A patent/RU2710736C2/ru not_active Application Discontinuation
- 2011-05-11 RU RU2019142507A patent/RU2019142507A/ru unknown
- 2011-05-11 JP JP2013510284A patent/JP5992399B2/ja active Active
- 2011-05-11 MX MX2012013083A patent/MX343721B/es active IP Right Grant
- 2011-05-11 BR BR122020018194-0A patent/BR122020018194B1/pt active IP Right Grant
- 2011-05-11 SG SG2012081436A patent/SG185424A1/en unknown
- 2011-05-11 CN CN2011800318199A patent/CN103002924A/zh active Pending
-
2012
- 2012-11-06 IL IL222897A patent/IL222897A/en active IP Right Grant
-
2016
- 2016-06-01 US US15/170,848 patent/US9682927B2/en active Active
- 2016-08-17 JP JP2016160146A patent/JP6216421B2/ja active Active
-
2017
- 2017-05-12 US US15/593,540 patent/US11174223B2/en active Active
-
2021
- 2021-07-28 US US17/387,478 patent/US20220017459A1/en not_active Abandoned
-
2025
- 2025-01-17 US US19/028,626 patent/US20250171398A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013528161A5 (cg-RX-API-DMAC7.html) | ||
| RU2012153210A (ru) | Композиции, способы и системы для синтеза и применение визуализирующих средств | |
| JP6685269B2 (ja) | 造影剤およびその中間体を合成するための方法および装置 | |
| KR101946089B1 (ko) | 영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템 | |
| CN108472242A (zh) | 治疗癌症的药物组合 | |
| JP2018076328A5 (cg-RX-API-DMAC7.html) | ||
| JP2006524250A5 (cg-RX-API-DMAC7.html) | ||
| US8815945B2 (en) | Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers | |
| JP2016204383A5 (cg-RX-API-DMAC7.html) | ||
| US20160296538A1 (en) | Predictive and response biomarker for th-302 anti-cancer therapy | |
| JP2015508068A5 (cg-RX-API-DMAC7.html) | ||
| Yu et al. | LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment | |
| JP2007500730A5 (cg-RX-API-DMAC7.html) | ||
| RU2020109705A (ru) | Соединения и их фармацевтические композиции для применения в лечении фиброзных заболеваний | |
| JP2012504581A5 (cg-RX-API-DMAC7.html) | ||
| JP2009538894A5 (cg-RX-API-DMAC7.html) | ||
| JP2023184564A (ja) | 新規化合物 | |
| JP2013507345A5 (cg-RX-API-DMAC7.html) | ||
| JP7036543B2 (ja) | 腫瘍イメージング剤、及びホウ素中性子捕捉療法用腫瘍治療剤 | |
| US20250090507A1 (en) | Methods of Treating Cancer With a B-RAF Inhibitor | |
| JP2012520855A5 (cg-RX-API-DMAC7.html) | ||
| US20150183780A1 (en) | Use of vegfr-3 inhibitors for treating hepatocellular carcinoma | |
| US20190255199A1 (en) | Non-invasive diagnostic imaging agent for heart disease | |
| US9205156B2 (en) | Molecular imaging agents | |
| JP2008500971A5 (cg-RX-API-DMAC7.html) |